Skip to main content
. 2020 Nov 5;30(11):1574–1578. doi: 10.1089/thy.2019.0589

Table 3.

Case Reports of Methimazole- or Carbimazole-Induced Acute Pancreatitis

Authors Reporting year Ethnicity Age Sex Diagnosis Time of symptom onset Drug Dose (mg) Management
Taguchi et al. (3) 1999 Japanese 66 W Graves' disease 21 days
3 hours after 2nd dose
MMI 30
10a
PTU
Marazuela et al. (4) 2002 Spanish 33 W Graves' disease 30 days
1 day
Carbimazole 45
10a
RAI
Su et al. (5) 2008 Chinese 19 W Graves' disease 75 days MMI 10 RAI
Chng et al. (6) 2011 Asian 70 W Graves' disease 14 days Carbimazole 30 RAI
Abraham et al. (7) 2012 Caucasian 80 W Unspecified 90 days MMI 10 Unspecified
Yang et al. (8) 2012 Chinese 18 W Graves' disease 4 days
Within 1 day
MMI 20
10b
10b
10b
PTU
Jung et al. (9) 2014 Korean 51 M Graves' disease 14 days 5 hours MMI 20
10a
Unspecified
Agito et al. (10) 2015 Caucasian 51 W Toxic MNG 21 days
5 days
MMI 10
10a
RAI
Kikuchi et al. (11) 2018 Japanese 76 W Graves' disease 19 days MMI 10 Potassium iodide

There is no report of recurrent rate of acute pancreatitis in patients who were not re-exposed to thionamides.

a

Rechallenged.

b

Rechallenged three times at different times by three physicians.

M, men; MMI, methimazole; MNG, multinodular goiter; PTU, propylthiouracil; RAI, radioactive iodine; W, women.